Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

More News

View More
News headline image
3 Big Dividend Stocks Just Raised Payouts—Here’s Who’s Leading in 2026 ↗
Via MarketBeat
Topics Artificial Intelligence Energy
Tickers AMZN ASX:RBD NEE PLD QSR
News headline image
The Supply Chain Quietly Powering the AI Boom—And 4 Ways to Play It ↗
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers AAPL AMAT AMD ASML ENTG NVDA
News headline image
Why Are Amphenol, Royal Caribbean, and Freeport Insiders Selling? ↗
Via MarketBeat
Tickers APH FCX RCL
News headline image
Hinge Health’s AI Moat Might Be Its Patient Movement Data ↗
Via MarketBeat
Topics Artificial Intelligence
Tickers HNGE UNH
News headline image
These 5 Stocks Are at the Center of the AI Supply Squeeze ↗
Via MarketBeat
Topics Artificial Intelligence
Tickers ASML GEV MSFT MU NBIS SNDK

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.90
-5.21 (-2.48%)
AAPL  266.58
+2.00 (0.76%)
AMD  195.33
-4.82 (-2.41%)
BAC  51.23
-1.83 (-3.44%)
GOOG  310.89
-4.01 (-1.27%)
META  636.68
-18.98 (-2.89%)
MSFT  383.51
-13.72 (-3.45%)
NVDA  190.89
+1.07 (0.56%)
ORCL  141.03
-7.05 (-4.76%)
TSLA  396.12
-15.70 (-3.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.